111 Price to Free Cash Flow Ratio 2018-2024 | YI

Historical price to free cash flow ratio values for 111 (YI) since 2018. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
111 Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-05-02 8.40 2.12
2024-12-31 6.23 $3.96 1.57
2024-09-30 7.56 $1.61 4.69
2024-06-30 10.65 $0.31 33.99
2024-03-31 11.60 $-3.74 0.00
2023-12-31 15.50 $-7.61 0.00
2023-09-30 26.00 $-3.53 0.00
2023-06-30 24.60 $-3.86 0.00
2023-03-31 26.50 $-1.75 0.00
2022-12-31 30.20 $-0.93 0.00
2022-09-30 26.80 $-8.66 0.00
2022-06-30 20.60 $-10.97 0.00
2022-03-31 26.60 $-10.72 0.00
2021-12-31 35.00 $-14.21 0.00
2021-09-30 61.70 $-10.35 0.00
2021-06-30 90.85 $-7.88 0.00
2021-03-31 138.00 $-5.50 0.00
2020-12-31 69.50 $-2.64 0.00
2020-09-30 62.00 $-1.13 0.00
2020-06-30 63.50 $-6.38 0.00
2020-03-31 66.10 $-10.18 0.00
2019-12-31 67.30 $-9.34 0.00
2019-09-30 48.70 $-12.89 0.00
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $0.072B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $38.476B 53.14
Tempus AI (TEM) US $9.826B 0.00
Hims & Hers Health (HIMS) US $9.069B 145.79
Inspire Medical Systems (INSP) US $4.756B 92.38
IRhythm Technologies (IRTC) US $4.185B 0.00
Privia Health (PRVA) US $2.829B 212.00
Enovis (ENOV) US $2.016B 12.47
Schrodinger (SDGR) US $1.847B 0.00
Clover Health Investments (CLOV) US $1.706B 0.00
Phreesia (PHR) US $1.512B 0.00
Omnicell (OMCL) US $1.460B 31.47
Azenta (AZTA) US $1.232B 57.36
10x Genomics (TXG) US $1.031B 0.00
Fulgent Genetics (FLGT) US $0.634B 0.00
Butterfly Network (BFLY) US $0.566B 0.00
Talkspace (TALK) US $0.537B 319.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.456B 0.00
TruBridge (TBRG) US $0.392B 0.00
Claritev (CTEV) US $0.362B 0.00
Health Catalyst (HCAT) US $0.294B 0.00
Nyxoah SA (NYXH) BE $0.208B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.202B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.116B 0.00
EUDA Health Holdings (EUDA) SG $0.097B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.081B 0.00
CareCloud (CCLD) US $0.080B 3.43
P3 Health Partners (PIII) US $0.063B 0.00
HeartBeam (BEAT) US $0.061B 0.00
Outset Medical (OM) US $0.044B 0.00
Zepp Health (ZEPP) CN $0.039B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Precipio (PRPO) US $0.011B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Healthcare Triangle (HCTI) US $0.009B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.005B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00